The chances for an offer are low as the offeror would face several hurdles. Nevertheless, the upcoming CARVYKTI commercial production in 2H24 will support the share price without an offer.
What is covered in the Full Insight:
Legend Biotech Takeover Rumors
Shareholder Responses and Market Reaction
Potential Offer and Shareholder Structure
Challenges to Takeover Offer
Conclusion and Future Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.